Opal Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Early Stage VC
  • (In Progress)

  • Latest Deal Amount
  • $200K

  • Investors
  • 7

Opal Therapeutics General Information

Description

Operator of a women's health biotechnology platform intended to advance drug discovery and translational research in gynecological disorders. The company offers two-dimensional and three-dimensional uterine organoid models, immune-competent systems, custom assay development, and artificial intelligence-based analysis, enabling pharmaceutical companies and research institutions to access clinically relevant human data, overcome limitations of animal models, and accelerate the development of effective therapeutics for gynecological conditions.

Contact Information

Website
www.opaltherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 135 Mississippi Street
  • San Francisco, CA 94107
  • United States
+1 (628)
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Other Healthcare Services
Drug Discovery
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • 135 Mississippi Street
  • San Francisco, CA 94107
  • United States
+1 (628)

Opal Therapeutics Timeline

20252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Opal Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Early Stage VC 30-Jan-2026 $200K In Progress Generating Revenue
7. Early Stage VC Completed Generating Revenue
6. Early Stage VC Completed Generating Revenue
5. Accelerator/Incubator 10-Sep-2025 Completed Generating Revenue
4. Accelerator/Incubator 08-May-2025 Completed Generating Revenue
3. Accelerator/Incubator 01-Feb-2025 Completed Startup
2. Accelerator/Incubator 06-Dec-2024 $220K $220K Completed Generating Revenue
1. Grant 21-Aug-2024 $295K Completed Generating Revenue
To view Opal Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Opal Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a women's health biotechnology platform intended to advance drug discovery and translational research in gyn
Biotechnology
San Francisco, CA
5 As of 2026

Boston, MA

Utrecht, Netherlands
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Opal Therapeutics Competitors (3)

One of Opal Therapeutics’s 3 competitors is Metri.Bio, a Venture Capital-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Metri.Bio Venture Capital-Backed Boston, MA
HUB Organoids Formerly Accelerator/Incubator backed Utrecht, Netherlands
Cyclana Bio Venture Capital-Backed Cambridge, United Kingdom
You’re viewing 3 of 3 competitors. Get the full list »

Opal Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Opal Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
California Life Sciences Accelerator/Incubator
National Science Foundation Innovation Corps Program Accelerator/Incubator
Techstars Accelerator/Incubator
US National Science Foundation Accelerator/Incubator
Bad Bitch Empire Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Opal Therapeutics FAQs

  • When was Opal Therapeutics founded?

    Opal Therapeutics was founded in 2024.

  • Where is Opal Therapeutics headquartered?

    Opal Therapeutics is headquartered in San Francisco, CA.

  • What is the size of Opal Therapeutics?

    Opal Therapeutics has 5 total employees.

  • What industry is Opal Therapeutics in?

    Opal Therapeutics’s primary industry is Biotechnology.

  • Is Opal Therapeutics a private or public company?

    Opal Therapeutics is a Private company.

  • What is Opal Therapeutics’s current revenue?

    The current revenue for Opal Therapeutics is .

  • How much funding has Opal Therapeutics raised over time?

    Opal Therapeutics has raised $320K.

  • Who are Opal Therapeutics’s investors?

    California Life Sciences, National Science Foundation Innovation Corps Program, Techstars, US National Science Foundation, and Bad Bitch Empire are 5 of 7 investors who have invested in Opal Therapeutics.

  • Who are Opal Therapeutics’s competitors?

    Metri.Bio, HUB Organoids, and Cyclana Bio are competitors of Opal Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process